無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

幹細胞治療の世界市場:2018年〜2022年

Global Stem Cell Therapy Market 2018-2022

発行 TechNavio (Infiniti Research Ltd.) 商品コード 439478
出版日 ページ情報 英文 102 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
幹細胞治療の世界市場:2018年〜2022年 Global Stem Cell Therapy Market 2018-2022
出版日: 2018年10月26日 ページ情報: 英文 102 Pages
概要

幹細胞療法について

幹細胞は、体内のほぼすべての細胞型に分化する能力を有し、外科および医学で使用されている細胞です。

Technavioのアナリストは、世界の幹細胞治療市場が、2018年から2022年に10.52%のCAGRで成長すると予測しています。

当レポートでは、世界の幹細胞治療市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 調査方法

第4章 市場状況

  • 市場のエコシステム
  • 市場特性
  • 市場セグメンテーション分析

第5章 パイプライン分析

  • パイプライン分析

第6章 市場規模

  • 市場の定義
  • 市場規模(2017年)
  • 市場規模および予測(2017年〜2022年)

第7章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市場状況

第8章 市場セグメンテーション:タイプ別

  • セグメンテーション:タイプ別(2017年〜2022年)
  • 比較:タイプ別
  • 自家移植
  • 同種移植
  • 市場機会:タイプ別

第9章 顧客情勢

第10章 地域情勢

  • 地域別セグメンテーション(2017年〜2022年)
  • 地域比較
  • 南北アメリカ
  • 欧州・中東・アフリカ地域
  • アジア太平洋地域
  • 市場機会

第11章 市場セグメンテーション:アプリケーション別

  • セグメンテーション:アプリケーション別

第12章 意思決定の枠組み

第13章 成長要因と課題

  • 市場の成長要因
  • 市場の課題

第14章 市場動向

  • コストの上昇
  • 償還
  • 慢性疾患治療の潜在的オプション
  • iPS細胞の開発

第15章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第16章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Gilead
  • Novartis
  • Organogenesis
  • Vericel

第17章 付録

  • 略語のリスト
図表
  • Exhibit 01: Parent market
  • Exhibit 02: Global regenerative medicines market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: List of pipeline stem cell therapies
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2017
  • Exhibit 08: Validation techniques employed for market sizing 2017
  • Exhibit 09: Global stem cell therapy market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 10: Global stem cell therapy market - Year over year growth 2017-2022 (%)
  • Exhibit 11: Five forces analysis 2017
  • Exhibit 12: Five forces analysis 2022
  • Exhibit 13: Bargaining power of buyers
  • Exhibit 14: Bargaining power of suppliers
  • Exhibit 15: Threat of new entrants
  • Exhibit 16: Threat of substitutes
  • Exhibit 17: Threat of rivalry
  • Exhibit 18: Market condition - Five forces 2017
  • Exhibit 19: Global stem cell therapy market by type - Market share 2017-2022 (%)
  • Exhibit 20: Comparison by type
  • Exhibit 21: Global stem cell therapy market by autologous transplants - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 22: Global stem cell therapy market by autologous transplants - Year over year growth 2017-2022 (%)
  • Exhibit 23: Global stem cell therapy market by allogeneic transplants - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 24: Global stem cell therapy market by allogeneic transplants - Year over year growth 2017-2022 (%)
  • Exhibit 25: Market opportunity by type
  • Exhibit 26: Customer landscape
  • Exhibit 27: Global stem cell therapy market by region - Market share 2017-2022 (%)
  • Exhibit 28: Regional comparison
  • Exhibit 29: Stem cell therapy market in Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 30: Stem cell therapy market in Americas - Year over year growth 2017-2022 (%)
  • Exhibit 31: Top three countries in Americas
  • Exhibit 32: Stem cell therapy market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 33: Stem cell therapy market in EMEA - Year over year growth 2017-2022 (%)
  • Exhibit 34: Top three countries in EMEA
  • Exhibit 35: Stem cell therapy market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 36: Stem cell therapy market in APAC - Year over year growth 2017-2022 (%)
  • Exhibit 37: Top three countries in Americas
  • Exhibit 38: Market opportunity
  • Exhibit 39: Types of accelerated approvals for stem cells
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Gilead overview
  • Exhibit 46: Gilead - Business segments
  • Exhibit 47: Gilead - Organizational developments
  • Exhibit 48: Gilead - Geographic focus
  • Exhibit 49: Gilead - Key offerings
  • Exhibit 50: Novartis overview
  • Exhibit 51: Novartis - Business segments
  • Exhibit 52: Novartis - Organizational developments
  • Exhibit 53: Novartis - Geographic focus
  • Exhibit 54: Novartis - Segment focus
  • Exhibit 55: Novartis - Key offerings
  • Exhibit 56: Organogenesis overview
  • Exhibit 57: Organogenesis - Product segments
  • Exhibit 58: Organogenesis - Organizational developments
  • Exhibit 59: Organogenesis - Key offerings
  • Exhibit 60: Vericel overview
  • Exhibit 61: Vericel - Business segments
  • Exhibit 62: Vericel - Organizational developments
  • Exhibit 63: Vericel - Key offerings
目次
Product Code: IRTNTR21031

About Stem Cell Therapy

Stem cells are cells that have the ability to divide and differentiate into almost every cell type in the body and used in surgery and medicine.

Technavio's analysts forecast the Global Stem Cell Therapy Market to grow at a CAGR of 10.52% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the stem cell therapy market. To calculate the market size, the report considers the revenue generated by the application of stem cell therapy across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Stem Cell Therapy Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Gilead
  • Novartis
  • Organogenesis
  • Vericel
  • Market driver
  • Increasing awareness about stem cell therapy across the globe
  • For a full, detailed list, view our report

Market challenge

  • High cost of clinical trials
  • For a full, detailed list, view our report

Market trend

  • Rising cost of stem cell therapy procedure
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: PIPELINE ANALYSIS

  • Pipeline analysis

PART 06: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 08: MARKET SEGMENTATION BY TYPE

  • Segmentation by type
  • Comparison by type
  • Autologous transplants - Market size and forecast 2017-2022
  • Allogeneic transplants - Market size and forecast 2017-2022
  • Market opportunity by type

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 11: MARKET SEGMENTATION BY APPLICATION

  • Segmentation by application

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 14: MARKET TRENDS

  • Rise in costs
  • Reimbursement
  • Potential curative option for chronic diseases
  • Development of iPS cells

PART 15: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 16: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Gilead
  • Novartis
  • Organogenesis
  • Vericel

PART 17: APPENDIX

  • List of abbreviations
Back to Top